William P. Keane

All filings by William P. Keane on record concern Salix Pharmaceuticals Ltd. We count 40 filings; the first trade dates from 28 February 2006 and the latest from 1 April 2015.

The open-market side counts 8 purchases for €17k alongside 7 sales for €3.0M. Taken together, the sales exceed the purchases by €3.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 18 share grants and 2 option exercises.

In size, the median ticket on the buying side is €2,379.

The record was last updated on 3 April 2015 with a transaction (€1.0M) in Salix Pharmaceuticals Ltd. The clock since the last published purchase (12 May 2008) now reads 6,739 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.